Published in Arch Fr Pediatr on March 01, 1983
Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell (2001) 6.10
The RNA-DNA hybrid maintains the register of transcription by preventing backtracking of RNA polymerase. Cell (1997) 4.10
A structural model of transcription elongation. Science (2000) 4.09
Photoradiation therapy for the treatment of malignant tumors. Cancer Res (1978) 4.01
Transcript cleavage factors from E. coli. Cell (1993) 3.78
Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase. J Biol Chem (1993) 3.07
Discontinuous mechanism of transcription elongation. Science (1994) 2.91
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Reliability of psychiatrists' ratings in community case finding. Am J Public Health Nations Health (1967) 2.64
Transcription processivity: protein-DNA interactions holding together the elongation complex. Science (1996) 2.58
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet (2004) 2.55
Intrinsic transcript cleavage activity of RNA polymerase. Proc Natl Acad Sci U S A (1995) 2.45
Mapping of catalytic residues in the RNA polymerase active center. Science (1996) 1.91
Recombinant Escherichia coli RNA polymerase: purification of individually overexpressed subunits and in vitro assembly. Protein Expr Purif (1993) 1.89
Location, structure, and function of the target of a transcriptional activator protein. Genes Dev (1994) 1.88
Coupling between transcription termination and RNA polymerase inchworming. Cell (1995) 1.86
GreA protein: a transcription elongation factor from Escherichia coli. Proc Natl Acad Sci U S A (1992) 1.85
Rapid RNA polymerase genetics: one-day, no-column preparation of reconstituted recombinant Escherichia coli RNA polymerase. Proc Natl Acad Sci U S A (1995) 1.85
Crystal structure of the GreA transcript cleavage factor from Escherichia coli. Nature (1995) 1.79
Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet (1997) 1.79
Reliability of newly trained raters in community case finding. Am J Public Health Nations Health (1967) 1.71
Comparison of cardiac catheterization and Doppler echocardiography in the decision to operate in aortic and mitral valve disease. J Am Coll Cardiol (1991) 1.57
Plasma chitotriosidase activity in patients with beta-thalassemia. Am J Hematol (2002) 1.55
Histidine-tagged RNA polymerase of Escherichia coli and transcription in solid phase. Methods Enzymol (1996) 1.53
Protein-RNA interactions in the active center of transcription elongation complex. Proc Natl Acad Sci U S A (1996) 1.52
Mutations in the consensus helicase domains of the Werner syndrome gene. Werner's Syndrome Collaborative Group. Am J Hum Genet (1997) 1.52
RifR mutations in the beginning of the Escherichia coli rpoB gene. Mol Gen Genet (1994) 1.52
Two modes of transcription initiation in vitro at the rrnB P1 promoter of Escherichia coli. J Biol Chem (1993) 1.51
Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst (1979) 1.50
Histidine-tagged RNA polymerase: dissection of the transcription cycle using immobilized enzyme. Gene (1993) 1.49
Cancer incidence and mortality among beta-naphthylamine and benzidine dye workers in Moscow. Int J Epidemiol (1995) 1.47
[Prevention of vitamin D deficiency in adolescents and pre-adolescents. An interventional multicenter study on the biological effect of repeated doses of 100,000 IU of vitamin D3]. Arch Pediatr (2000) 1.44
lac repressor acts by modifying the initial transcribing complex so that it cannot leave the promoter. Cell (1991) 1.44
Mapping of the priming substrate contacts in the active center of Escherichia coli RNA polymerase. J Biol Chem (1991) 1.41
Streptolydigin-resistant mutants in an evolutionarily conserved region of the beta' subunit of Escherichia coli RNA polymerase. J Biol Chem (1995) 1.38
[Retrospective analysis of 1331 samples of cerebrospinal fluid in newborn infants with suspected infection]. Arch Pediatr (1995) 1.38
Recombinant RNA polymerase: inducible overexpression, purification and assembly of Escherichia coli rpo gene products. Gene (1990) 1.36
The beta subunit Rif-cluster I is only angstroms away from the active center of Escherichia coli RNA polymerase. J Biol Chem (1995) 1.35
Toward localization of the Werner syndrome gene by linkage disequilibrium and ancestral haplotyping: lessons learned from analysis of 35 chromosome 8p11.1-21.1 markers. Am J Hum Genet (1996) 1.31
Mechanistic model of the elongation complex of Escherichia coli RNA polymerase. Cold Spring Harb Symp Quant Biol (1998) 1.28
Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int (1991) 1.27
Cardiopulmonary assessment in beta-thalassemia major. Chest (1990) 1.26
Blocking of the initiation-to-elongation transition by a transdominant RNA polymerase mutation. Science (1990) 1.24
The gene for the familial form of incontinentia pigmenti (IP2) maps to the distal part of Xq28. Hum Mol Genet (1994) 1.24
Modular organization of the catalytic center of RNA polymerase. Proc Natl Acad Sci U S A (1997) 1.22
A non-essential domain of Escherichia coli RNA polymerase required for the action of the termination factor Alc. J Biol Chem (1994) 1.20
Spatial organization of transcription elongation complex in Escherichia coli. Science (1998) 1.20
Structural modules of the large subunits of RNA polymerase. Introducing archaebacterial and chloroplast split sites in the beta and beta' subunits of Escherichia coli RNA polymerase. J Biol Chem (1996) 1.20
Homozygous and compound heterozygous mutations at the Werner syndrome locus. Hum Mol Genet (1996) 1.19
Mapping of a contact for the RNA 3' terminus in the largest subunit of RNA polymerase. J Biol Chem (1991) 1.19
A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry (2008) 1.18
Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis. J Pediatr Gastroenterol Nutr (1989) 1.18
Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial. J Pediatr (2001) 1.16
The sigma subunit conserved region 3 is part of "5'-face" of active center of Escherichia coli RNA polymerase. J Biol Chem (1994) 1.16
Diversity of beta-globin mutations in Israeli ethnic groups reflects recent historic events. Am J Hum Genet (1994) 1.16
Possible person-to-person transmission of Escherichia coli O111--associated hemolytic uremic syndrome. Pediatr Nephrol (1997) 1.14
Topology of the RNA polymerase active center probed by chimeric rifampicin-nucleotide compounds. Proc Natl Acad Sci U S A (1994) 1.12
Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families. Am J Hum Genet (1995) 1.10
Escherichia coli RNA polymerase holoenzyme: rapid reconstitution from recombinant alpha, beta, beta', and sigma subunits. Methods Enzymol (1996) 1.09
Homozygosity mapping of the Werner syndrome locus (WRN). Genomics (1994) 1.09
A beta subunit mutation disrupting the catalytic function of Escherichia coli RNA polymerase. Proc Natl Acad Sci U S A (1991) 1.09
Dominant lethal mutations near the 5' substrate binding site affect RNA polymerase propagation. J Biol Chem (1993) 1.08
Active center rearrangement in RNA polymerase initiation complex. J Biol Chem (1993) 1.07
In vitro transcription and isolation of a polycistronic RNA product of the T4 tRNA operon. Nature (1978) 1.05
Topology of the product binding site in RNA polymerase revealed by transcript slippage at the phage lambda PL promoter. J Biol Chem (1994) 1.04
Enhanced aggregability of red blood cells of beta-thalassemia major patients. Am J Physiol (1996) 1.02
In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol (1997) 1.02
Pneumocystis carinii detection using nested-PCR in nasopharyngeal aspirates of immunocompetent infants with bronchiolitis. J Eukaryot Microbiol (2001) 1.02
Bacteriophage T4 Alc protein: a transcription termination factor sensing local modification of DNA. Cell (1993) 1.02
Mapping of trypsin cleavage and antibody-binding sites and delineation of a dispensable domain in the beta subunit of Escherichia coli RNA polymerase. J Biol Chem (1991) 1.02
Transcriptional control of two gene subclusters in the tRNA operon of bacteriophage T4. Nature (1980) 1.01
Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects. J Pharm Sci (1981) 1.00
Competition between sigma factors for core RNA polymerase. Nucleic Acids Res (1987) 1.00
[Solitary upper incisor, hypopituitarism and monosomy 18p chromosome aberration]. J Genet Hum (1983) 0.99
Polymorphisms at the Werner locus: I. Newly identified polymorphisms, ethnic variability of 1367Cys/Arg, and its stability in a population of Finnish centenarians. Am J Med Genet (1999) 0.99
Mapping of transcription units in the bacteriophage T4 tRNA gene cluster. J Mol Biol (1981) 0.98
Cold sensitivity of thermophilic and mesophilic RNA polymerases. J Bacteriol (2004) 0.97
A validity study using the Leighton instrument. Am J Public Health (1971) 0.97
Liver transplantation for hereditary tyrosinemia: the Quebec experience. Am J Hum Genet (1990) 0.97
Initiation of transcription by bacteriophage T4-modified RNA polymerase independently of host sigma factor. J Mol Biol (1985) 0.95
The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis. J Med Genet (2001) 0.95
Development of a bone marrow culture for maintenance and growth of normal human B cell precursors. J Immunol (1991) 0.95
Cost-benefit analysis of a national thalassaemia prevention programme in Israel. J Med Screen (1998) 0.95
Hypomethylation of DNA derived from purified human erythroid cells correlates with gene activity of the beta-globin cluster. Blood (1985) 0.94
Assembly of functional Escherichia coli RNA polymerase containing beta subunit fragments. Proc Natl Acad Sci U S A (1995) 0.93
Effects of L-dopa in patients with dementia. Lancet (1970) 0.93
[Waardenburg's syndrome and severe cyanotic cardiopathy]. Arch Fr Pediatr (1990) 0.93
A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol (1999) 0.93
CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease. Leukemia (2007) 0.91
The Juberg-Marsidi syndrome maps to the proximal long arm of the X chromosome (Xq12-q21). Am J Hum Genet (1993) 0.90
In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood (1991) 0.90
Changes in the promoter range of RNA polymerase resulting from bacteriophage T4-induced modification of core enzyme. Proc Natl Acad Sci U S A (1981) 0.89
Enhanced adherence of beta-thalassaemic erythrocytes to endothelial cells. Br J Haematol (1999) 0.89
[Late neurological development of congenital toxoplasmosis demonstrated by study of the CSF]. Ann Pediatr (Paris) (1971) 0.89
Dissection of the beta subunit in the Escherichia coli RNA polymerase into domains by proteolytic cleavage. J Biol Chem (1992) 0.89
Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin Endocrinol (Oxf) (1993) 0.88